Bivalent vaccination against Salmonella Typhi and Paratyphi A
Typhoid and paratyphoid are serious bacterial infections that cause severe fevers, stomach pain, and headaches. While good vaccines exist for typhoid, there is currently no approved vaccine for paratyphoid. Researchers at the Oxford Vaccine Group are testing a new combined vaccine that aims to protect against both illnesses at the same time. In this Phase II trial, healthy volunteers aged 18 to 55 will be randomly chosen to receive either the new two-in-one vaccine or an existing standard typhoid vaccine. A few weeks later, participants will swallow a small, carefully measured dose of paratyphoid bacteria. Doctors will monitor everyone very closely to see if the new vaccine prevents illness. All volunteers receive a full course of antibiotics to clear the bacteria safely. The findings will help protect millions of people worldwide who live in or travel to areas without clean water.
At a glance
What is this study about?
Typhoid and paratyphoid fevers are serious illnesses known together as enteric fever. They are caused by related types of Salmonella bacteria, which spread through contaminated food and drinking water. Each year, around 13 million people across the globe catch enteric fever, leading to high fevers, severe stomach pain, headaches, and general exhaustion. Without quick medical care, it can cause dangerous complications. While safe and effective vaccines already protect travellers and communities against typhoid, there is currently no licensed jab to stop paratyphoid.
To tackle this gap, researchers have developed a new combined vaccine called SII-TCV(B). It is designed to train the immune system to fight off both typhoid and paratyphoid A bacteria at once. Early human testing has shown that the jab is safe and produces a promising immune response. This trial takes the next vital step to find out if the vaccine actually stops someone from becoming unwell when they encounter the bug in real life.
To test this, the Oxford Vaccine Group is using a 'controlled human infection' model. This means healthy adult volunteers will receive either the new vaccine or a standard typhoid jab, and later drink a liquid containing paratyphoid bacteria. Because the trial takes place in a carefully controlled environment with constant medical monitoring and prompt antibiotic treatment, doctors can safely learn whether the jab works. If successful, this new vaccine could save thousands of lives in places where clean water and sanitation are limited.
Key takeaways
- Tests a new two-in-one jab against both typhoid and paratyphoid A fevers.
- Open to healthy adults aged 18 to 55 who can attend clinic visits in Oxford.
- Involves swallowing a small dose of bacteria to test if the vaccine provides protection.
- Participants are monitored around the clock and given prompt antibiotic treatment.
- Helps develop life-saving vaccines for regions lacking clean water and sanitation.
Who may be eligible?
This study is open to healthy men and women aged between 18 and 55 years old. To take part, you must be in good general health, which the study doctors will confirm by reviewing your medical history and carrying out a physical health check. You must also give permission for the research team to view your NHS health records and contact your GP to check that joining is safe for you.
Because of the nature of the trial, participants must be able to attend all clinic appointments at the Oxford trial site and follow strict hygiene rules to prevent bacteria spreading to others. You will need reliable internet access to fill out a daily online symptom diary and a working mobile phone so the medical team can reach you at any time of day or night during the challenge period.
You cannot take part if you have underlying long-term health problems that affect your immune system, if you are unable to avoid pain-relieving medicines like ibuprofen during specific parts of the study, or if you cannot commit to the intensive safety follow-ups. You must also agree not to donate blood while enrolled in the trial.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged between 18 and 55 years old.
- I consider myself to be in good overall health.
- I can travel to the Oxford study clinic for multiple regular appointments.
- I have a mobile phone and can be reached 24 hours a day during key study weeks.
- I have internet access to complete a daily online health diary.
- I am willing to let researchers check my NHS records and contact my GP.
What does participation involve?
If you decide to join, your participation will begin with a screening appointment to check your health. If eligible, you will receive a single injection in your upper arm muscle. This will be either the new combined vaccine or a licensed typhoid vaccine, chosen at random. A few weeks after your jab, you will attend the clinic to drink a small, carefully prepared liquid containing paratyphoid bacteria. After this 'challenge', you will be monitored closely by doctors for four weeks, with frequent clinic check-ups and a 24-hour medical helpline available. You will take a full course of curative antibiotics starting either 14 days after drinking the liquid or sooner if you develop symptoms. You will also log your temperature and symptoms daily in an online diary. The overall trial runs between 2024 and 2027, and your individual involvement will last several months from your first visit to your final safety check.
Potential risks and benefits
Locations (14)
- Oxford Vaccine GroupApproximateOxford, England
- John Radcliffe HospitalApproximateOxford, England
- Queen Elizabeth HospitalApproximateBirmingham, England
- University Hospitals Bristol and Weston NHS Foundation TrustCity onlyBristol, England
- University Hospital of WalesApproximateCardiff, Wales
- Castle Hill HospitalApproximateCottingham, England
- Liverpool School of Tropical MedicineApproximateLiverpool, England
- North Manchester General HospitalApproximateManchester, England
- Royal Victoria InfirmaryApproximateNewcastle upon Tyne, England
- The Univ of Nottingham Health ServCity onlyNottingham, England
- St Georges Vaccine InstituteUnverifiedLondon, England
- Royal Hallamshire HospitalUnverifiedSheffield, England
Common questions
Why do researchers give volunteers live bacteria to drink?
Drinking a small, controlled amount of bacteria allows doctors to test directly whether a new vaccine prevents infection, rather than waiting years to see if people encounter it naturally.
Could I pass paratyphoid on to my family or housemates?
The risk is very low if you follow standard handwashing and hygiene guidance. The team will give you clear instructions and offer free, voluntary testing to the people you live with.
What happens if I start feeling ill during the study?
You will have direct, 24-hour telephone access to the medical team. If you develop a fever or other symptoms, doctors will assess you promptly and start antibiotic treatment straight away.
Will I be paid for taking part in this trial?
Volunteers are compensated for their time, travel, and the inconvenience involved in attending regular clinic visits and completing daily diaries.
Can I leave the study early if I change my mind?
Yes, you can leave at any point. However, if you have already swallowed the bacteria, you must finish your prescribed course of antibiotics to ensure your health and safety.
How to find out more
Sophie Vernon
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.